Methylprednisolone Recruiting Phase 2 Trials for Necrosis / Peripapillary Crescent / IgA Glomerulonephritis / Steroid Nephropathy Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02160132A Controlled Study of Steroids Therapy for Patients of IgA Nephropathy With Active Pathological Changes.